Deep brain stimulation (DBS) of the subthalamic nucleus and globus pallidus internus is FDA-approved for treating dystonia, showing positive effects on symptoms.
However, patient outcomes post-surgery can differ widely, prompting the search for new targets in neuromodulation.
Recent research has identified promising alternative DBS targets and examined non-invasive methods to better understand the disease's underlying mechanisms.